Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Ann Arbor, Michigan 48109


Purpose:

The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.


Study summary:

To evaluate the proportions of correct diagnosis of response to breast Cancer therapies for localized breast cancer by ultrasound. To develop a model based on patient characteristics, physical exam, and radiologic studies which will predict the possibility that a patient has had a complete pathological response to chemotherapy neoadjuvant therapy.


Criteria:

Inclusion Criteria: - Newly diagnosed breast cancer prior to receiving breast cancer therapy. - Diagnosis of breast cancer must be confirmed by fine needle aspiration or core biopsy. Exclusion Criteria: - Poorly controlled diabetes. - Contralateral mastectomy prior to neoadjuvant chemotherapy. - Not a surgical candidate. - No previous axillary lymph node dissection.


NCT ID:

NCT00721903


Primary Contact:

Principal Investigator
Paul L. Carson, Ph.D.
University of Michigan


Backup Contact:

N/A


Location Contact:

Ann Arbor, Michigan 48109
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.